Isoxazol-5(2H)-one: a new scaffold for potent human neutrophil elastase (HNE) inhibitors

Claudia Vergelli, Igor A. Schepetkin, Letizia Crocetti, Antonella Iacovone, Maria Paola Giovannoni, Gabriella Guerrini, Andrei I. Khlebnikov, Samuele Ciattini, Giovanna Ciciani, Mark T. Quinn

Research output: Contribution to journalArticle

9 Citations (Scopus)

Abstract

Human neutrophil elastase (HNE) is an important target for the development of novel and selective inhibitors to treat inflammatory diseases, especially pulmonary pathologies. Here, we report the synthesis, structure–activity relationship analysis, and biological evaluation of a new series of HNE inhibitors with an isoxazol-5(2H)-one scaffold. The most potent compound (2o) had a good balance between HNE inhibitory activity (IC50 value =20 nM) and chemical stability in aqueous buffer (t 1/2=8.9 h). Analysis of reaction kinetics revealed that the most potent isoxazolone derivatives were reversible competitive inhibitors of HNE. Furthermore, since compounds 2o and 2s contain two carbonyl groups (2-N-CO and 5-CO) as possible points of attack for Ser195, the amino acid of the active site responsible for the nucleophilic attack, docking studies allowed us to clarify the different roles played by these groups.

Original languageEnglish
Pages (from-to)821-831
Number of pages11
JournalJournal of Enzyme Inhibition and Medicinal Chemistry
Volume32
Issue number1
DOIs
Publication statusPublished - 1 Jan 2017

Fingerprint

Secretory Proteinase Inhibitory Proteins
Leukocyte Elastase
Carbon Monoxide
Lung Diseases
Inhibitory Concentration 50
Catalytic Domain
Buffers
Pathology
Amino Acids
azastene

Keywords

  • chemical stability
  • HNE inhibitor
  • human neutrophil elastase
  • Isoxazol-5(2H)-one
  • molecular docking

ASJC Scopus subject areas

  • Pharmacology
  • Drug Discovery

Cite this

Isoxazol-5(2H)-one : a new scaffold for potent human neutrophil elastase (HNE) inhibitors. / Vergelli, Claudia; Schepetkin, Igor A.; Crocetti, Letizia; Iacovone, Antonella; Giovannoni, Maria Paola; Guerrini, Gabriella; Khlebnikov, Andrei I.; Ciattini, Samuele; Ciciani, Giovanna; Quinn, Mark T.

In: Journal of Enzyme Inhibition and Medicinal Chemistry, Vol. 32, No. 1, 01.01.2017, p. 821-831.

Research output: Contribution to journalArticle

Vergelli, C, Schepetkin, IA, Crocetti, L, Iacovone, A, Giovannoni, MP, Guerrini, G, Khlebnikov, AI, Ciattini, S, Ciciani, G & Quinn, MT 2017, 'Isoxazol-5(2H)-one: a new scaffold for potent human neutrophil elastase (HNE) inhibitors', Journal of Enzyme Inhibition and Medicinal Chemistry, vol. 32, no. 1, pp. 821-831. https://doi.org/10.1080/14756366.2017.1326915
Vergelli, Claudia ; Schepetkin, Igor A. ; Crocetti, Letizia ; Iacovone, Antonella ; Giovannoni, Maria Paola ; Guerrini, Gabriella ; Khlebnikov, Andrei I. ; Ciattini, Samuele ; Ciciani, Giovanna ; Quinn, Mark T. / Isoxazol-5(2H)-one : a new scaffold for potent human neutrophil elastase (HNE) inhibitors. In: Journal of Enzyme Inhibition and Medicinal Chemistry. 2017 ; Vol. 32, No. 1. pp. 821-831.
@article{8f0c43d3bb6242798db37a48e6427981,
title = "Isoxazol-5(2H)-one: a new scaffold for potent human neutrophil elastase (HNE) inhibitors",
abstract = "Human neutrophil elastase (HNE) is an important target for the development of novel and selective inhibitors to treat inflammatory diseases, especially pulmonary pathologies. Here, we report the synthesis, structure–activity relationship analysis, and biological evaluation of a new series of HNE inhibitors with an isoxazol-5(2H)-one scaffold. The most potent compound (2o) had a good balance between HNE inhibitory activity (IC50 value =20 nM) and chemical stability in aqueous buffer (t 1/2=8.9 h). Analysis of reaction kinetics revealed that the most potent isoxazolone derivatives were reversible competitive inhibitors of HNE. Furthermore, since compounds 2o and 2s contain two carbonyl groups (2-N-CO and 5-CO) as possible points of attack for Ser195, the amino acid of the active site responsible for the nucleophilic attack, docking studies allowed us to clarify the different roles played by these groups.",
keywords = "chemical stability, HNE inhibitor, human neutrophil elastase, Isoxazol-5(2H)-one, molecular docking",
author = "Claudia Vergelli and Schepetkin, {Igor A.} and Letizia Crocetti and Antonella Iacovone and Giovannoni, {Maria Paola} and Gabriella Guerrini and Khlebnikov, {Andrei I.} and Samuele Ciattini and Giovanna Ciciani and Quinn, {Mark T.}",
year = "2017",
month = "1",
day = "1",
doi = "10.1080/14756366.2017.1326915",
language = "English",
volume = "32",
pages = "821--831",
journal = "Journal of Enzyme Inhibition and Medicinal Chemistry",
issn = "1475-6366",
publisher = "Informa Healthcare",
number = "1",

}

TY - JOUR

T1 - Isoxazol-5(2H)-one

T2 - a new scaffold for potent human neutrophil elastase (HNE) inhibitors

AU - Vergelli, Claudia

AU - Schepetkin, Igor A.

AU - Crocetti, Letizia

AU - Iacovone, Antonella

AU - Giovannoni, Maria Paola

AU - Guerrini, Gabriella

AU - Khlebnikov, Andrei I.

AU - Ciattini, Samuele

AU - Ciciani, Giovanna

AU - Quinn, Mark T.

PY - 2017/1/1

Y1 - 2017/1/1

N2 - Human neutrophil elastase (HNE) is an important target for the development of novel and selective inhibitors to treat inflammatory diseases, especially pulmonary pathologies. Here, we report the synthesis, structure–activity relationship analysis, and biological evaluation of a new series of HNE inhibitors with an isoxazol-5(2H)-one scaffold. The most potent compound (2o) had a good balance between HNE inhibitory activity (IC50 value =20 nM) and chemical stability in aqueous buffer (t 1/2=8.9 h). Analysis of reaction kinetics revealed that the most potent isoxazolone derivatives were reversible competitive inhibitors of HNE. Furthermore, since compounds 2o and 2s contain two carbonyl groups (2-N-CO and 5-CO) as possible points of attack for Ser195, the amino acid of the active site responsible for the nucleophilic attack, docking studies allowed us to clarify the different roles played by these groups.

AB - Human neutrophil elastase (HNE) is an important target for the development of novel and selective inhibitors to treat inflammatory diseases, especially pulmonary pathologies. Here, we report the synthesis, structure–activity relationship analysis, and biological evaluation of a new series of HNE inhibitors with an isoxazol-5(2H)-one scaffold. The most potent compound (2o) had a good balance between HNE inhibitory activity (IC50 value =20 nM) and chemical stability in aqueous buffer (t 1/2=8.9 h). Analysis of reaction kinetics revealed that the most potent isoxazolone derivatives were reversible competitive inhibitors of HNE. Furthermore, since compounds 2o and 2s contain two carbonyl groups (2-N-CO and 5-CO) as possible points of attack for Ser195, the amino acid of the active site responsible for the nucleophilic attack, docking studies allowed us to clarify the different roles played by these groups.

KW - chemical stability

KW - HNE inhibitor

KW - human neutrophil elastase

KW - Isoxazol-5(2H)-one

KW - molecular docking

UR - http://www.scopus.com/inward/record.url?scp=85020515003&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85020515003&partnerID=8YFLogxK

U2 - 10.1080/14756366.2017.1326915

DO - 10.1080/14756366.2017.1326915

M3 - Article

AN - SCOPUS:85020515003

VL - 32

SP - 821

EP - 831

JO - Journal of Enzyme Inhibition and Medicinal Chemistry

JF - Journal of Enzyme Inhibition and Medicinal Chemistry

SN - 1475-6366

IS - 1

ER -